Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

20081,063 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 372, Issue 9645, pp. 1240-1250

Field-Weighted Citation Impact: 47.80